Continuation of follow-up of DES-exposed cohorts
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201500028C
- Awardee
-
The University Of Chicago UEI ZUE9HKT2CLC9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,104,182
Award facts
- Opportunity
-
- N02CP5101258 Solicitation number
- Contract value 100% obligated
- $1,104,181.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Chicago, IL 60637, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$13,088 | |
| Funding Only Action | -$4,268 | |
| Exercise an Option | $216,973 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $151,440 | |
| Exercise an Option | $253,568 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $252,696 | |
| Original award | $246,861 |
About this award
This is a Cost No Fee definitive contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of Chicago. The contract, valued at $1,104,181.80, is for the continuation of follow-up of diethylstilbestrol (DES)-exposed cohorts. The contract does not have a set-aside designation. As a major recipient of federal research funding, the University of Chicago conducts cutting-edge research across various disciplines, often in collaboration with other institutions. The university also holds a significant $146.3 million indefinite delivery contract (IDV) with the National Institute of Allergy and Infectious Diseases (NIAID) for the evaluation and development of animal and animal replacement models for screening and assessing candidate countermeasures such as therapeutics, vaccines, and diagnostics.
Quick answers
Who was awarded contract HHSN261201500028C?
HHSN261201500028C was awarded to The University Of Chicago by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500028C worth?
The government has obligated $1,104,182 on HHSN261201500028C.
Was contract HHSN261201500028C competed?
The extent of competition for HHSN261201500028C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award